Chemiluminescence immunoassay amplified by functional acridinium ester for the detection of NT-proBNP in clinical samples
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Epilepsy research and treatment · Heart Failure Treatment and Management · Transplantation: Methods and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Obesity and the risk of heart failure10.1056/NEJMoa020245 ↗
2. Neurogenesis in stroke recovery10.1007/s12975-016-0460-z ↗
3. Prevalence, incidence and survival of heart failure: a systematic review10.1136/heartjnl-2021-320131 ↗
4. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease10.1038/s41581-022-00616-6 ↗
5. Demographic and regional trends of heart failure-related mortality in young adults in the US, 1999-201910.1001/jamacardio.2022.2213 ↗
6. B-type natriuretic peptide in cardiovascular disease10.1016/S0140-6736(03)13976-1 ↗
7. Specificity of B-type natriuretic peptide assays: cross-reactivity with different BNP, NT-ProBNP, and ProBNP peptides10.1373/clinchem.2016.263749 ↗
8. B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease10.1186/s12916-019-1306-9 ↗
9. Plasma natriuretic peptide levels and the risk of cardiovascular events anddeath10.1056/NEJMoa031994 ↗
10. BNP and heart failure: preclinical and clinical trial data10.1007/s12265-015-9619-3 ↗
11. Bedside diagnosis of coronary artery disease: a systematic review10.1016/j.amjmed.2004.03.021 ↗
12. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review10.1373/clinchem.2006.075713 ↗
13. Recent advances in point-of-care testing for natriuretic peptides: potential impact on heart failure diagnosis and management10.1586/14737159.2016.1158105 ↗
14. Towards point-of-care heart failure diagnostic platforms: BNP and NT-proBNP biosensors10.3390/s19225003 ↗
15. Radioimmunoassay for brain natriuretic peptide (BNP) detection of BNP in canine brain10.1016/S0006-291X(89)80186-X ↗
16. A specific and highly sensitive radioimmunoassay of human brain natriuretic peptide
17. Analytical validation of an immunoassay for the quantification of N-terminal pro-B-type natriuretic peptide in feline blood10.1177/1040638715588330 ↗
18. Quantum dot enabled lateral flow immunoassay for detection of cardiac biomarker NT-proBNP10.1016/j.sbsr.2018.10.002 ↗
19. Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure10.1515/CCLM.2002.130 ↗
20. Comparison of immunoassays for NTproBNP conducted on three analysis systems: milliplex, Elecsys and RIA10.1016/j.clinbiochem.2012.11.022 ↗
21. Dry-reagent microfluidic biosensor for simple detection of NT-proBNP via Ag nanoparticles10.1016/j.aca.2021.339375 ↗
22. Highly-sensitive electrochemiluminescence biosensor for NT-proBNP using MoS2@Cu2S as signal-enhancer and multinary nanocrystals loaded in mesoporous UiO-66-NH2 as novel luminophore
23. Chemiluminescence as diagnostic tool: a review10.1016/S0039-9140(99)00294-5 ↗
24. Research progress on chemiluminescence immunoassay combined with novel technologies10.1016/j.trac.2019.115780 ↗
25. A review of recent trends in analytical applications of electrogenerated chemiluminescence10.1016/S0165-9936(98)00086-7 ↗
26. A sequential dual-lock strategy for photoactivatable chemiluminescent probes enabling bright duplex optical imaging10.1002/anie.202000165 ↗
27. Near-Infrared AIE dots with chemiluminescence for deep-tissue imaging10.1002/adma.202004685 ↗
28. Strong chemiluminescence intensities of bis-acridinium esters under neutral and alkaline conditions10.1016/j.dyepig.2023.111175 ↗
29. Circularly polarized peroxyoxalate chemiluminescence with chiral activators10.1016/j.dyepig.2023.111513 ↗
30. A graphene-based composite material noncovalently functionalized with a chemiluminescence reagent: synthesis and intrinsic chemiluminescence activity10.1039/c2cc17674b ↗
31. Fabrication of luminol and lucigenin bifunctionalized gold nnanoparticles/graphene oxide nanocomposites with dual-wavelength chemiluminescence10.1021/jp303304z ↗
32. High-density assembly of chemiluminescence functionalized gold nanodots on multiwalled carbon nanotubes and their application as biosensing platforms10.1039/c3nr05574d ↗
33. Single-walled carbon nanotubes noncovalently functionalized by ruthenium(II) complex tagged with pyrene: electrochemical and electrogenerated chemiluminescence properties10.1002/chem.201201543 ↗
34. Design of acridinium-9-carboxamides and anti-acridinium antibodies for chemiluminescent signal enhancement10.1021/bc000152j ↗
35. Enhancement effect on the chemiluminescence of acridinium esters under neutral conditions10.1002/bio.3419 ↗
36. Synthesis and properties of chemiluminescent acridinium ester labels with fluorous tags10.1039/C4OB00456F ↗
37. Acridinium salt-based fluoride and acetate chromofluorescent probes: molecular insights into anion selectivity switching10.1021/ol901935g ↗
38. Chemoselective reaction of bifunctional carboxysulfonic acid systems: preparation of useful intermediates for chemiluminescent, fluorescent and UV absorbing bifunctional linkers10.1016/j.tetlet.2020.152332 ↗
39. Dye disaggregation light-up aptamer for super-resolution RNA imaging10.1016/j.snb.2023.133731 ↗
40. Orderly self-assembly of organic fluorophores for sensing and imaging
41. Preparation of near-infrared AIEgen-active fluorescent probes for mapping amyloid-βplaques in brain tissues and living mice10.1038/s41596-022-00789-1 ↗
42. Activatable near-infrared versatile fluorescent and chemiluminescent dyes based on the dicyanomethylene-4H-pyran scaffold: from design to imaging and theranostics
43. Washing-free chemiluminescence immunoassay for rapid detection of cardiac troponin I in whole blood samples10.1016/j.cclet.2021.07.017 ↗
44. Development of a rapid and ultrasensitive magnetic chemiluminescence immunoassay for the detection of adiponectin and its clinical application10.1016/j.jpba.2024.115961 ↗
45. Rapid and sensitive detection of L-FABP for prediction and diagnosis of acute kidney injury in critically ill patients by chemiluminescent immunoassay10.1002/jcla.24051 ↗